GalenicaGALNF 80 EBIT per Share is $5.87 as of Dec. 2025. GuruFocus rates GALNF with a GF Score™ of 80/100 and a GF Value™ of $117.23. The stock has 1 warning sign investors should review. Among 107 Medical Distribution companies, Galenica ranks better than 58.88% on this metric.
Galenica's EBIT per Share for the
six
months ended in Dec. 2025 was $3.06.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $5.87.
During the past 12 months, the average EBIT per Share Growth Rate of Galenica was 10.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 6.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 1.90% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 8.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Galenica's EBIT per Share or its related term are showing as below:
GALNF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -3 Med: 6.7 Max: 22.1
Current: 6.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Galenica was 22.10% per year. The lowest was -3.00% per year. And the median was 6.70% per year.
GALNF's 3-Year EBIT Growth Rate is ranked better than 58.88% of 107
companies
in the Medical Distribution industry
Industry Median: 4.2
vs GALNF: 6.70
Galenica's EBIT for the
six
months ended in Dec. 2025 was $152 Mil.
Galenica (OTCPK:GALNF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Galenica EBIT per Share Related Terms
Galenica EBIT per Share Historical Data
* Premium members only.
The historical data trend for Galenica's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $5.87
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galenica (GALNF) has a EBIT per Share of $5.87 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Galenica and its competitors. According to the industry distribution chart, Galenica ranks #44 out of 107 companies in the Medical Distribution industry, placing it in the top 41.1%.
Is Galenica's EBIT per Share too high?
Galenica's current EBIT per Share is $5.87. The Medical Distribution industry median EBIT per Share is 4.20. Galenica's value of $5.87 is 39.8% above this industry median. Based on the distribution chart, Galenica ranks #44 out of 107 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Galenica has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Galenica's EBIT per Share compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Galenica ranks #44 out of 107 companies for EBIT per Share. This puts Galenica in the upper half of its industry. The industry median EBIT per Share is 4.20. Galenica's value of $5.87 is 39.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.20, based on 107 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galenica's current EBIT per Share of $5.87 is 39.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Galenica and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galenica's current EBIT per Share is $5.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Galenica (GALNF) has a current EBIT per Share of $5.87. The stock's GF Value™ is $117.23, compared to a current price of $115.00 — trading 1.9% below its estimated fair value. The current EBIT per Share is $5.87 and 39.8% above the Medical Distribution industry median of 4.20. Galenica's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Galenica (GALNF), the current EBIT per Share is $5.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Galenica (GALNF) Overvalued in 2026?
Based on GuruFocus' analysis, Galenica stock appears to be undervalued.
The current stock price of $115.00 is trading 1.9% below its estimated GF Value™ of $117.23.
Key valuation signals for GALNF:
EBIT per Share: $5.87
GF Value™: $117.23 vs. price of $115.00 (1.9% below fair value)
Industry Position: 39.8% above the Medical Distribution median (#44 of 107)
No single metric tells the full story. See the GALNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
80GF Score
Get the complete analysis for GALNF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GALNF has been successfully added to your 
